D.E. Shaw & Co’s Biohaven BHVN Stock Holding History

D.E. Shaw & Co’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-45,100	Closed	-$509K	–	4557
2025 Q4	$509K	Buy	+45,100	New	+$559K	﹤0.01%	3923

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

D.E. Shaw & Co's BHVN Position: Q2 2026 in Review

D.E. Shaw & Co increased its Biohaven (BHVN) stake by 47% in Q2 2026, buying an estimated $14.5M and bringing the position to 4,190,195 shares worth $62.4M. The position accounts for 0.03% of the portfolio, ranked #652.

D.E. Shaw & Co first reported a position in BHVN in Q4 2022 and has held it in 13 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

D.E. Shaw & Co held 4,190,195 shares of Biohaven worth $62.4M as of Q2 2026.
D.E. Shaw & Co bought 1,343,002 Biohaven shares in Q2 2026, an estimated $14.5M.
Biohaven made up 0.03% of D.E. Shaw & Co's portfolio in Q2 2026, its #652 holding.
D.E. Shaw & Co first reported a position in Biohaven in Q4 2022 and has held it in 13 quarters since.
296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.